Health Secretary Robert F. Kennedy Jr. faced bipartisan criticism on Capitol Hill over his department’s budget cuts, vaccine statements, and controversial fluoride and drug policy proposals.

A presidential executive order signed Monday sets a 30-day deadline for drugmakers to electively lower prices in the U.S.

Robert F. Kennedy Jr. testified on May 14 before the House Appropriations and the Senate Health, Education, Labor and Pensions committees.

Lawmakers seek answers to questions about sweeping cuts to federal public health infrastructure but Kennedy stays mum.

This is misleading. Prices for most prescription drugs — unbranded generics are the exception — are higher in the U.S. than ...

Health and Human Services Secretary Robert Kennedy Jr. defended proposed 2026 budget reductions during separate House and ...

U.S. health secretary Robert F. Kennedy Jr. said on Wednesday at a Senate Committee on Health, Education, Labor & Pensions ...

Robert F. Kennedy Jr. goes to Capitol Hill to promote and defend his massive overhaul of HHS, and President Trump's plans to ...

From my colleague Jason Mast: The first ever patient has been treated with prime editing, a powerful technology for making ...

Dr. Oz, Administrator of the Centers for Medicare & Medicaid Services, joins MSNBC’s Ari Melber for an extended conversation on the Trump administration’s plan to lower prescription drug prices, the ...

President Trump has signed his executive order seeking lower prescription drug prices. It gives the pharmaceutical industry ...

The president claimed his “most-favored nation” proposal would reduce some pharmaceutical prices by as much as 80%, but the ...